Although its fate was in doubt more than a few times, the Affordable Care Act turned 12 this week. Year 13 could be pivotal in determining how many Americans receive ACA health insurance, and at what price. Meanwhile, three leading credit bureaus agreed to stop using most medical debt to measure U.S. consumers’ creditworthiness. Anna Edney of Bloomberg News, Rachel Cohrs of Stat, and KHN’s Mary Agnes Carey join KHN’s Julie Rovner to discuss these issues and more.
Nashville nurse RaDonda Vaught is charged with reckless homicide for giving the wrong medication to a patient at Vanderbilt University Medical Center.
Former nurse RaDonda Vaught is on trial for reckless homicide, and her case raises consequential questions about how nurses use computerized medication-dispensing cabinets.
Experts are concerned that flashy Silicon Valley technology won’t reach those most in need of treatment for substance use disorders.
Five states have created “assistant physician” licenses that allow medical school graduates to practice without completing residency training. But a federal indictment in Missouri of one assistant physician has some original supporters trying to rein in the medical specialty.
Even a personal finance expert can get stuck with a huge unexpected bill for a drug. Listen up for what you need to know about “copay accumulators.”
KHN senior correspondents Jenny Gold and Anna Maria Barry-Jester joined KVPR’s Kathleen Schock on “Valley Edition” to discuss their investigation into the abrupt closure of one of California’s largest chain of pain clinics — and the patients left behind.
The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
U.S. and global drug manufacturers invested in Russia’s sizable pharmaceutical industry contend international humanitarian law requires they continue manufacturing and selling their products there, even while condemning the Ukraine invasion. Not everyone agrees.
Like others in academia or government who’ve served as public health advisers during the pandemic, Dr. Michael Mina traded his university role for a commercial venture. He recently took a top job at eMed, a startup that charges a premium price for monitoring at-home covid tests. Can experts do well by trying to do good?
